OverviewSuggest Edit

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer. It works on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells that inhibit the cancer-fighting humoral immune system. 


Latest Updates

Employees (est.) (Feb 2020)4

Navrogen Financials and Metrics

Summary Metrics

Founding Date


Navrogen total Funding

$3.2 m

Navrogen latest funding size

$3.20 m

Time since last funding

5 months ago

Navrogen investors

Navrogen's latest funding round in September 2019 was reported to be $3.2 m. In total, Navrogen has raised $3.2 m
Show all financial metrics

Navrogen Online and Social Media Presence

Embed Graph

Navrogen Frequently Asked Questions

  • When was Navrogen founded?

    Navrogen was founded in 2017.

  • How many employees does Navrogen have?

    Navrogen has 4 employees.

  • Who are Navrogen competitors?

    Competitors of Navrogen include Thermosome, Prelude Therapeutics and Apollomics.